Medtronic plc (MDT) reported adjusted earnings per share (EPS) of $1.26 for the second-quarter fiscal 2025, up 0.8% from the year-ago quarter’s figure. The figure also beat the Zacks Consensus Estimate by 1.61%. Currency-adjusted EPS for the reported quarter was $1.35.Without certain one-time adjustments — including amortization, restructuring and associated costs, certain litigation charges and acquisition-related costs, among others — GAAP EPS was 99 cents, a 45.6% improvement from the year-ago quarter’s ...

For the quarter ended October 2024, Medtronic (MDT) reported revenue of $8.4 billion, up 5.3% over the same period last year. EPS came in at $1.26, compared to $1.25 in the year-ago quarter.The reported revenue represents a surprise of +1.75% over the Zacks Consensus Estimate of $8.26 billion. With the consensus EPS estimate being $1.24, the EPS surprise was +1.61%.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectat ...

Core Points - Medtronic reported quarterly earnings of $1.26 per share, exceeding the Zacks Consensus Estimate of $1.24 per share, and showing a slight increase from $1.25 per share a year ago, resulting in an earnings surprise of 1.61% [1] - The company achieved revenues of $8.4 billion for the quarter ended October 2024, surpassing the Zacks Consensus Estimate by 1.75% and increasing from $7.98 billion year-over-year [2] - Medtronic has consistently surpassed consensus EPS estimates over the last four quarters, indicating strong performance [2] Future Outlook - The immediate price movement of Medtronic's stock will largely depend on management's commentary during the earnings call and future earnings expectations [3] - Current consensus EPS estimate for the upcoming quarter is $1.37 on revenues of $8.41 billion, while for the current fiscal year, it is $5.44 on revenues of $33.6 billion [8] - The estimate revisions trend for Medtronic is mixed, resulting in a Zacks Rank 3 (Hold), suggesting the stock is expected to perform in line with the market in the near future [7] Industry Context - The Medical - Products industry, to which Medtronic belongs, is currently in the top 50% of Zacks industries, indicating a favorable outlook compared to the bottom 50% [9] - Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can be tracked by investors [6]

Exhibit 99.1 Erika Winkels Ryan Weispfenning Public Relations Investor Relations +1-763-526-8478 +1-763-505-4626 NEWS RELEASE Contacts: FOR IMMEDIATE RELEASE Medtronic reports second quarter fiscal 2025 financial results Delivering on commitments, executing ahead of expectations, and raising guidance Innovation driving sustained growth across many franchises: TAVR, PFA, Leadless Pacemakers, Diabetes, Spine, and Neuromodulation GALWAY, Ireland – Nov. 19, 2024 – Medtronic plc (NYSE: MDT) today announced finan ...

Delivering on commitments, executing ahead of expectations, and raising guidanceInnovation driving sustained growth across many franchises:  TAVR, PFA, Leadless Pacemakers, Diabetes, Spine, and NeuromodulationGALWAY, Ireland, Nov. 19, 2024 /PRNewswire/ -- Medtronic plc (NYSE: MDT) today announced financial results for its second quarter (Q2) of fiscal year 2025 (FY25), which ended October 25, 2024.Key Highlights Revenue of $8.4 billion increased 5.3% as reported and 5.0% organic GAAP diluted earnings per ...

Analysts on Wall Street project that Medtronic (MDT) will announce quarterly earnings of $1.24 per share in its forthcoming report, representing a decline of 0.8% year over year. Revenues are projected to reach $8.26 billion, increasing 3.5% from the same quarter last year. The current level reflects no revision in the consensus EPS estimate for the quarter over the past 30 days. This demonstrates how the analysts covering the stock have collectively reappraised their initial projections over this period. A ...

Dr. Shirin Towfigh thought she had designed a medical device that would revolutionize hernia care for women. Now, Towfigh is suing Medtronic, a global leader in medical devices, accusing the company of stealing her patented design. A Beverly Hills surgeon with over 22 years of experience, Towfigh says she discovered that a significant number of her hernia patients experiencing post-surgery complications were women — and that most mesh designs on the market were primarily tailored to the male anatomy.In 2016 ...

HONG KONG and SHANGHAI, Nov. 7, 2024 /PRNewswire/ -- Ping An Healthcare and Technology Company Limited ("Ping An Good Doctor", "Ping An Health", or "the Company", Stock Code: 1833.HK) established a strategic partnership with Medtronic (Shanghai) Management Co., Ltd. ("Medtronic") at the 7th China International Import Expo (CIIE) held at the National Exhibition and Convention Center (Shanghai) on 6 November, 2024. Leveraging their respective strengths, the two companies will collaborate extensively on cardia ...

Medtronic plc (MDT) is scheduled to report second-quarter fiscal 2025 results on Nov. 19, before the opening bell. In the last reported quarter, the company's adjusted earnings of $1.23 exceeded the Zacks Consensus Estimate by 2.5%. Medtronic beat estimates in each of the trailing four quarters, the average surprise being 3.07%. The Zacks Consensus Estimate for fiscal second-quarter revenues is pegged at $8.26 billion, suggesting growth of 3.5% year over year. The consensus estimate for second-quarter earni ...

Financial Results Announcement - Medtronic plc will report its financial results for the second quarter of fiscal year 2025 on November 19, 2024, with a news release at approximately 5:45 a.m. CST [1] - The second quarter ended on October 25, 2024, and the summary financial information will be included in the news release [1] Webcast Details - A video webcast to discuss the second quarter results will be hosted by Medtronic at 7:00 a.m. CST on November 19, 2024 [2] - The webcast can be accessed through Medtronic's investor relations website, and a replay and transcript will be available within 24 hours of the broadcast [2] Future Reporting Schedule - Medtronic plans to report its third quarter results on February 18, 2025, and the fourth quarter results on May 21, 2025 [3] Company Overview - Medtronic is a leading global healthcare technology company headquartered in Galway, Ireland, with over 95,000 employees across more than 150 countries [4] - The company focuses on addressing challenging health problems and offers technologies that treat 70 health conditions, including cardiac devices, surgical robotics, and patient monitoring systems [4] - Medtronic's mission is to alleviate pain, restore health, and extend life, delivering innovative technologies that transform lives [4]